2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

908. Outcomes Research: Myeloid Malignancies: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Molecular Testing, Emerging Technologies, Treatment Considerations, Combination Therapy, Drug Development, Supportive Care, Therapy Sequence, Biological Therapies, Transfusion, Vaccines, Non-Biological Therapies, Pharmacology, Adverse Events, Artificial Intelligence (AI), Natural Language Processing, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Diseases, Lymphoid Malignancies, Lymphoid Leukemias, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Measurable Residual Disease, ALL, Research, AML, APL, MDS, MPN, CML, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Survivorship, Study Population, Human, Adult, Elderly, Young Adult
PAPER

6355 Higher county-level debt burden is independently associated with inferior five‑year survival in acute myeloid leukemia

Laura Rolke, PhD, MPH, Danielle Boselli, MS2, Jing Ai, MD, PhD3, Brittany Knick Ragon, MD4, Aleksander Chojecki, MD5, Nilay Shah, MD6, Srinivasa Reddy Sanikommu, MD7, Kelly Brook Weaver, DNP, APRN, ACNS-BC, NP-C, OCN, AOCNP8, Lawrence J Druhan, PhD9, Michael R. Grunwald, MD10, Thomas G Knight, MD11
1 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
2 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
3 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
4 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
5 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
6 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
7 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
8 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
9 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
10 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States
11 Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, United States

Introduction: Curative-intent treatment of acute myeloid leukemia (AML) relies on complex, resource-intensive care with prolonged hospitalizations, frequent outpatient monitoring, transfusion support, and referral for allogeneic hematopoietic stem cell transplantation in eligible patients. However, access to this care may be influenced by broader socioeconomic and structural conditions. Debt in collections is a community-level measure of financial instability that may capture house-hold level financial strain which would be a barrier to sustained cancer care.  The objective of this study is to examine if county-level debt burden, measured as share of residents with debt in collections, is associated with poorer 5-year survival outcomes among adults aged 18 to 60 years with AML.

Methods: We conducted a retrospective cohort study using the National Cancer Institute’s specialized SEER 17 Research Plus Incidence Database (covering 26.5% of the U.S. population) with county-level identifiers. Adults aged 18–60 years with AML (ICD-O-3/WHO 2008 definition) diagnosed between 2003 and 2017 were included. Patients with mixed phenotypic acute leukemia, those diagnosed at death, and those with missing survival time were excluded. The Urban Institute’s Debt in America county-level debt dataset (2025) was matched by FIPS codes to SEER patients. Counties across the United States were placed into quintiles based on the proportion of county residents with any debt in collections (ranging from 5.7% to 50.3%). Descriptive statistics, Kaplan Meier methods, and Cox Proportional Hazards models (debt as continuous and quintiles) were conducted for 5-year overall (OS) and cancer-specific survival (CSS) in R Studio. Covariates include age group, sex, race/ethnicity, first versus subsequent primary cancer diagnosis, and diagnosis time group.

Results: There were 13,163 patients included in the analysis; the sample had an average age of 45.9 years old and primarily included non-Hispanic White individuals (n=7,890, 60.0%). The 3 four-year diagnosis time blocks were evenly distributed (ranging from 29.1% to 36.8%) and there were slightly more males than females (52.3% to 47.7%). Patients were distributed unequally across county-level debt share quintiles: Q1 (n=4,449, 33.8%), Q2 (n=3,316, 25.3%), Q3 (n=2,638, 20.0%), Q4 (n=1,333, 10.1%), and Q5 (n=1,425, 10.8%).

5-year overall survival (OS) declined as county-level debt burden increased: Q1 = 37.6%, Q2 = 35.8%, Q3 = 34.4%, Q4 = 31.6%, and Q5 = 29.9%.  Cancer-specific survival (CSS) followed a similar trend and dropped from 42.0% in Q1 to 36.7% in Q5.

In multivariable Cox regression, higher county-level debt burden was independently associated with an increased risk of death, corresponding to a 6.7% higher hazard of death for every 10-percentage-point increase in the proportion of residents with debt in collections (HR=1.93 per 100-percentage-point increase, p<0.001). This was also confirmed in the county-level debt quintile analysis; compared to Q1, the risk of death from any cause in 5-years was significantly higher in Q3 (HR= 1.18; 95% CI: 1.07-1.30; p<0.001), Q4 (HR=1.25; 95% CI: 1.13-1.37; p<0.001), and Q5 (HR=1.35; 95% CI:1.22-1.49; p<0.001). Covariates behaved as expected, with older age, non-Hispanic Black race, and AML as a non-primary cancer diagnosis associated with increased mortality risk; female sex and more recent year of diagnosis was associated with lower mortality risk. 

Conclusions: Higher county-level debt burden was independently associated with inferior 5-year survival outcomes for individuals living in counties with a greater proportion of debt. Patients residing in counties with the highest debt burden had a 7.7 percentage point difference in 5-year OS, and a 35% higher adjusted OS mortality risk compared with those in the lowest-debt counties.  County-level debt in collections may capture financial distress not fully reflected by traditional demographic variables and represents a measurable marker of community-level financial distress associated with worse survival in acute leukemias. County-level debt metrics may offer a scalable approach to identify patients with acute leukemia who could benefit from proactive financial intervention at diagnosis.

Thomas G Knight, MD: No relevant conflicts of interest to declare.